Reinhild Kappelhoff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Reinhild Kappelhoff has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Christopher M. Overall
University of British Columbia
4 shared publications - Georgina S. Butler
Centre for Blood Research, Life Sciences Centre, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada
4 shared publications - Isabel Pablos
Centre for Blood Research, Life Sciences Centre, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada
4 shared publications - Peter M. Grin
Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada
4 shared publications - Hugo César Ramos de Jesus
Centre for Blood Research, Life Sciences Centre, University of British Columbia, Vancouver, British Columbia, V6T 1Z3, Canada
3 shared publications - Peter A. Bell
Centre for Blood Research, University of British Columbia, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada; Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada
3 shared publications
Latest Publications
- Open Access
Interferon redundancy counteracts proteolytic inactivation by SARS-CoV-2 3CL pro main protease
: Interferons (IFNs) are secreted during virus infection and induce antiviral responses through receptor-mediated phosphorylation of signal transducer and activator of transcription (STAT) proteins, leading to IFN-stimulated gene expression with antiviral activity. We previously reported that the SARS-CoV-2 main protease, 3CL pro , is secreted from infected cells through gasdermin D/E pores and retains proteolytic activity in human serum against extracellular substrates. Here, we show that 3CL pro selectively cleaves glycosylated IFN-λ1, IFN-λ2, and a rare naturally occurring variant of IFN-γ (Arg160Gln), but does not cleave wild-type IFN-γ, IFN-λ3, IFN-λ4, IFN-α proteins or IFN-β. We identified sites of O-linked glycosylation of IFN-λ1 at Thr 137 and one or more threonines or serine in the sequence 24 TSKPTTT 30 , and N-linked glycosylation at Asn 65 that were indispensable for signaling. Unexpectedly, O-glycosylation was also required for the cleavage and inactivation of IFN-λ1 by 3CL pro at two sites. Cleavage reduced STAT1 phosphorylation and impaired the induction of the IFN-stimulated proteins MX1, OAS2, and IFIT1. Although 3CL pro cleaved IFN-λ2 proximal to its N-terminus at ARLH 32 ↓GALP, cleavage neither disrupted signaling nor antiviral activity against SARS-CoV-2 and vesicular stomatitis virus. We further show that matrix metalloproteinases (MMPs) 2, 7, 8, and 12 degrade 3CL pro , whereas 3CL pro shows no activity against these MMPs. IMPORTANCE: Extracellular cleavage of IFN-λ1 and IFN-λ2, and the selective inactivation of IFN-λ1 by 3CL pro , reveals a potential pathobiological role for secreted SARS-CoV-2 3CL pro . The redundancy of IFN signaling, together with differential cleavage susceptibilities of IFNs to 3CL pro and the degradation of 3CL pro by several secreted MMPs, provide host countermeasures that preserve antiviral defence in some settings. Our findings highlight the potential to discover additional extracellular 3CL pro substrates that may contribute to SARS-CoV-2 replication and COVID-19. The investigation of potential secretion, extracellular activity, and host substrates of proteases encoded by other virus families, including Picornaviridae, Flaviviridae, Adenoviridae, and Poxviridae, is also warranted. Finally, our findings support the development of cleavage-resistant IFN-λ1 as a potential broad-spectrum antiviral therapeutic.
Open AccessInterferon redundancy counteracts proteolytic inactivation by SARS-CoV-2 3CL pro main protease
: Interferons (IFNs) are secreted during virus infection and induce antiviral responses through receptor-mediated phosphorylation of signal transducer and activator of transcription (STAT) proteins, leading to IFN-stimulated gene expression with antiviral activity. We previously reported that the SARS-CoV-2 main protease, 3CL pro , is secreted from infected cells through gasdermin D/E pores and retains proteolytic activity in human serum against extracellular substrates. Here, we show that 3CL pro selectively cleaves glycosylated IFN-λ1, IFN-λ2, and a rare naturally occurring variant of IFN-γ (Arg160Gln), but does not cleave wild-type IFN-γ, IFN-λ3, IFN-λ4, IFN-α proteins or IFN-β. We identified sites of O-linked glycosylation of IFN-λ1 at Thr 137 and one or more threonines or serine in the sequence 24 TSKPTTT 30 , and N-linked glycosylation at Asn 65 that were indispensable for signaling. Unexpectedly, O-glycosylation was also required for the cleavage and inactivation of IFN-λ1 by 3CL pro at two sites. Cleavage reduced STAT1 phosphorylation and impaired the induction of the IFN-stimulated proteins MX1, OAS2, and IFIT1. Although 3CL pro cleaved IFN-λ2 proximal to its N-terminus at ARLH 32 ↓GALP, cleavage neither disrupted signaling nor antiviral activity against SARS-CoV-2 and vesicular stomatitis virus. We further show that matrix metalloproteinases (MMPs) 2, 7, 8, and 12 degrade 3CL pro , whereas 3CL pro shows no activity against these MMPs. IMPORTANCE: Extracellular cleavage of IFN-λ1 and IFN-λ2, and the selective inactivation of IFN-λ1 by 3CL pro , reveals a potential pathobiological role for secreted SARS-CoV-2 3CL pro . The redundancy of IFN signaling, together with differential cleavage susceptibilities of IFNs to 3CL pro and the degradation of 3CL pro by several secreted MMPs, provide host countermeasures that preserve antiviral defence in some settings. Our findings highlight the potential to discover additional extracellular 3CL pro substrates that may contribute to SARS-CoV-2 replication and COVID-19. The investigation of potential secretion, extracellular activity, and host substrates of proteases encoded by other virus families, including Picornaviridae, Flaviviridae, Adenoviridae, and Poxviridae, is also warranted. Finally, our findings support the development of cleavage-resistant IFN-λ1 as a potential broad-spectrum antiviral therapeutic.
- Open Access
- 12 December 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (12) , 115080
SARS-CoV-2 3CLpro (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CLpro
- 12 December 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (12) , 115080
Open AccessSARS-CoV-2 3CLpro (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CLpro
- Open Access
- 13 June 2024
- Published by American Society for Microbiology in Journal of Virology
- Vol. 98 (6) , e0004924
Optimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL pro main protease (Mpro) from proteomic identification of P6—P6' active site specificity
SARS-CoV-2 3C-like main protease (3CL pro ) is essential for protein excision from the viral polyprotein. 3CL pro inhibitor drug development to block SARS-CoV-2 replication focuses on the catalytic non-prime (P) side for specificity and potency, but the importance of the prime (P') side in substrate specificity and for drug development remains underappreciated. We determined the P6–P6' specificity for 3CL pro from >800 cleavage sites that we identified using Proteomic Identification of Cleavage site Specificity (PICS). Cleavage occurred after the canonical P1-Gln and non-canonical P1-His and P1-Met residues. Moreover, P3 showed a preference for Arg/Lys and P3' for His. Essential H-bonds between the N-terminal Ser1 of protomer-B in 3CL pro dimers form with P1-His, but not with P1-Met. Nonetheless, cleavage occurs at P1-Met456 in native MAP4K5. Elevated reactive oxygen species in SARS-CoV-2 infection oxidize methionines. Molecular simulations revealed P1-Met OX forms an H-bond with Ser1 and notably, strong positive cooperativity between P1-Met with P3'-His was revealed, which enhanced peptide-cleavage rates. The highly plastic S3' subsite accommodates P3′-His that displays stabilizing backbone H-bonds with Thr25 lying central in a “‘threonine trio” (Thr24-Thr25-Thr26) in the P'-binding domain I. Molecular docking simulations unveiled structure-activity relationships impacting 3CL pro -substrate interactions, and the role of these structural determinants was confirmed by MALDI-TOF-MS cleavage assays of P1'- and P3'-positional scanning peptide libraries carrying a 2nd optimal cut-site as an internal positive control. These data informed the design of two new and highly soluble 3CL pro quenched-fluorescent peptide substrates for improved FRET monitoring of 3CL pro activity with 15× improved sensitivity over current assays. IMPORTANCE: From global proteomics identification of >800 cleavage sites, we characterized the P6–P6' active site specificity of SARS-CoV-2 3CL pro using proteome-derived peptide library screens, molecular modeling simulations, and focussed positional peptide libraries. In P1', we show that alanine and serine are cleaved 3× faster than glycine and the hydrophobic small amino acids Leu, Ile, or Val prevent cleavage of otherwise optimal non-prime sequences. In characterizing non-canonical non-prime P1 specificity, we explored the unusual P1-Met specificity, discovering enhanced cleavage when in the oxidized state (P1-Met OX ). We unveiled unexpected amino acid cooperativity at P1-Met with P3′-His and noncanonical P1-His with P2-Phe, and the importance of the threonine trio (Thr24-Thr25-Thr26) in the prime side binding domain I in defining prime side binding in SARS-CoV-2 3CL pro . From these analyses, we rationally designed quenched-fluorescence natural amino acid peptide substrates with >15× improved sensitivity and high peptide solubility, facilitating handling and application for screening of new antiviral drugs.
- 13 June 2024
- Published by American Society for Microbiology in Journal of Virology
- Vol. 98 (6) , e0004924
Open AccessOptimization of quenched fluorescent peptide substrates of SARS-CoV-2 3CL pro main protease (Mpro) from proteomic identification of P6—P6' active site specificity
SARS-CoV-2 3C-like main protease (3CL pro ) is essential for protein excision from the viral polyprotein. 3CL pro inhibitor drug development to block SARS-CoV-2 replication focuses on the catalytic non-prime (P) side for specificity and potency, but the importance of the prime (P') side in substrate specificity and for drug development remains underappreciated. We determined the P6–P6' specificity for 3CL pro from >800 cleavage sites that we identified using Proteomic Identification of Cleavage site Specificity (PICS). Cleavage occurred after the canonical P1-Gln and non-canonical P1-His and P1-Met residues. Moreover, P3 showed a preference for Arg/Lys and P3' for His. Essential H-bonds between the N-terminal Ser1 of protomer-B in 3CL pro dimers form with P1-His, but not with P1-Met. Nonetheless, cleavage occurs at P1-Met456 in native MAP4K5. Elevated reactive oxygen species in SARS-CoV-2 infection oxidize methionines. Molecular simulations revealed P1-Met OX forms an H-bond with Ser1 and notably, strong positive cooperativity between P1-Met with P3'-His was revealed, which enhanced peptide-cleavage rates. The highly plastic S3' subsite accommodates P3′-His that displays stabilizing backbone H-bonds with Thr25 lying central in a “‘threonine trio” (Thr24-Thr25-Thr26) in the P'-binding domain I. Molecular docking simulations unveiled structure-activity relationships impacting 3CL pro -substrate interactions, and the role of these structural determinants was confirmed by MALDI-TOF-MS cleavage assays of P1'- and P3'-positional scanning peptide libraries carrying a 2nd optimal cut-site as an internal positive control. These data informed the design of two new and highly soluble 3CL pro quenched-fluorescent peptide substrates for improved FRET monitoring of 3CL pro activity with 15× improved sensitivity over current assays. IMPORTANCE: From global proteomics identification of >800 cleavage sites, we characterized the P6–P6' active site specificity of SARS-CoV-2 3CL pro using proteome-derived peptide library screens, molecular modeling simulations, and focussed positional peptide libraries. In P1', we show that alanine and serine are cleaved 3× faster than glycine and the hydrophobic small amino acids Leu, Ile, or Val prevent cleavage of otherwise optimal non-prime sequences. In characterizing non-canonical non-prime P1 specificity, we explored the unusual P1-Met specificity, discovering enhanced cleavage when in the oxidized state (P1-Met OX ). We unveiled unexpected amino acid cooperativity at P1-Met with P3′-His and noncanonical P1-His with P2-Phe, and the importance of the threonine trio (Thr24-Thr25-Thr26) in the prime side binding domain I in defining prime side binding in SARS-CoV-2 3CL pro . From these analyses, we rationally designed quenched-fluorescence natural amino acid peptide substrates with >15× improved sensitivity and high peptide solubility, facilitating handling and application for screening of new antiviral drugs.
- Open Access
- 9 October 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (4) , 109892
Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome
- 9 October 2021
- Published by Elsevier in Cell Reports
- Vol. 37 (4) , 109892
Open AccessMechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome